A phase 3 trial shows that ivarmacitinib improves symptoms in adults with moderate to severe atopic dermatitis compared with ...

Jason Hawkes, MD, MS, provided an in-depth look at the potential role of dupilumab (Dupixent; Sanofi and Regeneron ...

For over a year, Polly, from Scotland, has been battling painful dermatitis on her hands, and despite her efforts no treatment has alleviated the issue. The 52-year-old tried various steroid creams, ...

You know that burning or crawling sensation that makes you want to scratch dry skin? It's awful—especially when it's in a ...

The eyelids may be the first area of the ... What is your current treatment and how long have you used these treatments? Antigens may cause dermatitis even if used only on occasion.

Belarus Atopic dermatitis (AD) is a common inflammatory skin disease. Most cases start in children although some have been reported in adults. Moderate to severe cases of AD not responding to topical ...

All products featured on Self are independently selected by our editors. However, we may receive compensation from retailers and/or from purchases of products through these links. No matter how ...

For patients with eyelid allergic contact dermatitis (ACD), a broad patch testing assessment supports optimal individualized treatment when other triggers for ACD are ruled out and routine care proves ...

Atopic dermatitis (AD) is a complex systemic disease characterized by high heterogeneity both at clinical and pathophysiology levels. While advances in drug development toward a more targeted approach ...

Raj Chovatiya, MD, PhD, MSCI, highlights promising research in atopic dermatitis focused on identifying patient subgroups for targeted treatments and achieving long-term remission. Raj Chovatiya ...

Yet even though people of color are more likely to have atopic dermatitis and to experience more severe symptoms, they’re less likely to receive treatments for it. A study published in 2024 ...